Policy | June 28, 2022
R&D key for the growth of nation: Dr. Mandaviya
The Minister lauded and extended his gratitude to the scientists who developed the vaccine during pandemic.
The Minister lauded and extended his gratitude to the scientists who developed the vaccine during pandemic.
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
Strengthens investment in channels of the future to expand patient reach
The Congress was held on June, 20-21, 2022 in Berlin, Germany
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
Tabrecta is the number one prescribed targeted therapy for advanced NSCLC with alterations leading to METex14 skipping globally
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
Subscribe To Our Newsletter & Stay Updated
